Meta-analysis of efficacy and safety of Yttrium-90 radioembolization (TARE) in the treatment of advanced hepatocellular carcinoma.

Front Nucl Med · 2026 · PMC13044050 · PMID 41938734

Europe PMC DOI

hedged sentence

0.9100

closest p · 18.2× alpha

0.9100

boldest claim

The sentences

a favorable trendP = 0.91not close (p > 0.1)

For PFS, stratification by study design showed consistent results: retrospective studies (HR = 2.73, 95% CI: 1.58–4.73) and prospective studies (HR = 1.65, 95% CI: 0.87–3.15) both indicated a favorable trend toward TARE, with no significant subgroup effect ( P = 0.91).

also in 1,335 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.